The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. (Q38217657)

From Wikidata

Jump to navigation Jump to search

scientific article published on 04 June 2014

Language	Label	Description	Also known as
English	The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.	scientific article published on 04 June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Kenneth K Tanabe

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

0 references

publication date

4 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

120

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2824-2838

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Predictors and patterns of recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Understanding surgical decision making in early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Randomized controlled trial of screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Diagnostic imaging of hepatocellular carcinoma: recent progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Extrahepatic Metastases of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prospective validation of the Barcelona Clinic Liver Cancer staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Resection and liver transplantation for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

World review of laparoscopic liver resection-2,804 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Image-guided liver surgery: intraoperative projection of computed tomography images utilizing tracked ultrasound.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Evolution of image-guided liver surgery: transition from open to laparoscopic procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: transplantation or resection?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Results of liver transplantation: with or without Milan criteria?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

New trends and novel treatment for hepatocellular carcinoma: a global perspective.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

"Infectious" optimism for treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

21 January 2018

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Small hepatocellular carcinoma. Detection with US, CT, MR imaging, DSA, and Lipiodol-CT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value and tolerance of Lipiodol-computed tomography for the detection of small hepatocellular carcinoma: correlation with pathologic examination of explanted livers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative portal vein embolization for major liver resection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28730

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28730

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24897995%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38217657&oldid=1873265569"